Naftaly Meydan

Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

Naftaly Meydan, T Grunberger, Harjit Dadi et al. · Nature · 1996 · 910 citations

Hematological Malignancy, Malignant Blood Disorder, Immunology +4

Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA

Inés Santisteban, F X Arredondo-Vega, S Kelly et al. · Human Molecular Genetics · 1995 · 61 citations

Impact of active monitoring of infection control practices on deep sternal infection after open-heart surgery

Abraham Borer, Jacob Moran‐Gilad, Naftaly Meydan et al. · The Annals of Thoracic Surgery · 2001 · 48 citations · Full text

Cardiac Anaesthesia, Healthcare-associated Infection, Patient Safety +10

Impact of regular attendance by infectious disease specialists on the management of hospitalised adults with community-acquired febrile syndromes

Abraham Borer, Jacob Moran‐Gilad, Naftaly Meydan et al. · Clinical Microbiology and Infection · 2004 · 27 citations · Full text

Primary Care, Medicine, Healthcare-associated Infection +7

Immune function in patients with β thalassaemia receiving the orally active iron‐chelating agent deferiprone

Ronen Loebstein, Ilan Dalal, Eric Nisbet‐Brown et al. · British Journal of Haematology · 1997 · 17 citations · Full text